
BioIVT acquires research services company XenoTech
BioIVT has acquired XenoTech, a provider of products and services for preclinical testing that specialises in ADME, DMPK and DDI testing of potential drug candidates. Through the acquisition, BioIVT aims to expand the portfolio of research models and services that are available to its clients to support… Read More
